APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

COVID-19 Drug API

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global COVID-19 Drug API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173981280319 December 2025181 pages

Choose your research edition.

Industry ResearchCOVID-19 Drug API Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal COVID-19 Drug API Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal COVID-19 Drug API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal COVID-19 Drug API Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal COVID-19 Drug API Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global COVID-19 Drug API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for COVID-19 Drug API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for COVID-19 Drug API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for COVID-19 Drug API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for COVID-19 Drug API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of COVID-19 Drug API include Chongqing Kangle Pharmaceutical Co., Ltd., Fuan Pharmaceutical Group, Wuhan Wuyao Pharmaceutical Co., Ltd, Cinkate, Shanghai Zhongxi Sunve Pharma Co., Ltd. and Shenhua Pharmaceutical Co., Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global COVID-19 Drug API market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of COVID-19 Drug API and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents COVID-19 Drug API revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the COVID-19 Drug API market size, projected growth trends, production technologies, key applications, and end-use industries.

COVID-19 Drug API Segment by Company

Chongqing Kangle Pharmaceutical Co., Ltd.

Fuan Pharmaceutical Group

Wuhan Wuyao Pharmaceutical Co., Ltd

Cinkate

Shanghai Zhongxi Sunve Pharma Co., Ltd.

Shenhua Pharmaceutical Co., Ltd

COVID-19 Drug API Segment by Type

Hydroxychloroquine

Chloroquine Phosphate

Others

COVID-19 Drug API Segment by Application

Tablet

Injection

COVID-19 Drug API Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global COVID-19 Drug API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of COVID-19 Drug API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of COVID-19 Drug API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of COVID-19 Drug API in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global COVID-19 Drug API industry.

Chapter 3: Detailed analysis of COVID-19 Drug API companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, COVID-19 Drug APIrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global COVID-19 Drug API Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Hydroxychloroquine Table 3. Key Players of Chloroquine Phosphate Table 4. Key Players of Others Table 4. Global COVID-19 Drug API Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Tablet Table 6. Key Players of Injection Table 7. Global COVID-19 Drug API Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global COVID-19 Drug API Market Size by Region (2021-2026) & (US$ Million) Table 9. Global COVID-19 Drug API Market Share by Region (2021-2026) Table 10. Global COVID-19 Drug API Market Size by Region (2027-2032) & (US$ Million) Table 11. Global COVID-19 Drug API Market Share by Region (2027-2032) Table 12. COVID-19 Drug API Industry Trends Table 13. COVID-19 Drug API Industry Drivers Table 14. COVID-19 Drug API Industry Opportunities and Challenges Table 15. COVID-19 Drug API Industry Restraints Table 16. Global COVID-19 Drug API Revenue by Company (US$ Million) & (2021-2026) Table 17. Global COVID-19 Drug API Revenue Market Share by Company (2021-2026) Table 18. Global COVID-19 Drug API Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global COVID-19 Drug API Key Company Head Office and Area Served Table 20. Global COVID-19 Drug API Company, Product Type & Application Table 21. Global COVID-19 Drug API Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global COVID-19 Drug API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global COVID-19 Drug API Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global COVID-19 Drug API Market Size by Type (2021-2026) & (US$ Million) Table 26. Global COVID-19 Drug API Market Size by Type (2027-2032) & (US$ Million) Table 27. Global COVID-19 Drug API Revenue Market Share by Type (2021-2026) Table 28. Global COVID-19 Drug API Revenue Market Share by Type (2027-2032) Table 29. Global COVID-19 Drug API Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global COVID-19 Drug API Market Size by Application (2021-2026) & (US$ Million) Table 31. Global COVID-19 Drug API Market Size by Application (2027-2032) & (US$ Million) Table 32. Global COVID-19 Drug API Revenue Market Share by Application (2021-2026) Table 33. Global COVID-19 Drug API Revenue Market Share by Application (2027-2032) Table 34. Chongqing Kangle Pharmaceutical Co., Ltd. Company Information Table 35. Chongqing Kangle Pharmaceutical Co., Ltd. Business Overview Table 36. Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Product Portfolio Table 38. Chongqing Kangle Pharmaceutical Co., Ltd. Recent Development Table 39. Fuan Pharmaceutical Group Company Information Table 40. Fuan Pharmaceutical Group Business Overview Table 41. Fuan Pharmaceutical Group COVID-19 Drug API Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Fuan Pharmaceutical Group COVID-19 Drug API Product Portfolio Table 43. Fuan Pharmaceutical Group Recent Development Table 44. Wuhan Wuyao Pharmaceutical Co., Ltd Company Information Table 45. Wuhan Wuyao Pharmaceutical Co., Ltd Business Overview Table 46. Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Product Portfolio Table 48. Wuhan Wuyao Pharmaceutical Co., Ltd Recent Development Table 49. Cinkate Company Information Table 50. Cinkate Business Overview Table 51. Cinkate COVID-19 Drug API Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Cinkate COVID-19 Drug API Product Portfolio Table 53. Cinkate Recent Development Table 54. Shanghai Zhongxi Sunve Pharma Co., Ltd. Company Information Table 55. Shanghai Zhongxi Sunve Pharma Co., Ltd. Business Overview Table 56. Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Product Portfolio Table 58. Shanghai Zhongxi Sunve Pharma Co., Ltd. Recent Development Table 59. Shenhua Pharmaceutical Co., Ltd Company Information Table 60. Shenhua Pharmaceutical Co., Ltd Business Overview Table 61. Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Product Portfolio Table 63. Shenhua Pharmaceutical Co., Ltd Recent Development Table 64. North America COVID-19 Drug API Market Size by Type (2021-2026) & (US$ Million) Table 65. North America COVID-19 Drug API Market Size by Type (2027-2032) & (US$ Million) Table 66. North America COVID-19 Drug API Market Size by Application (2021-2026) & (US$ Million) Table 67. North America COVID-19 Drug API Market Size by Application (2027-2032) & (US$ Million) Table 68. North America COVID-19 Drug API Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 69. North America COVID-19 Drug API Market Size by Country (2021-2026) Table 70. North America COVID-19 Drug API Market Size by Country (2027-2032) Table 71. Europe COVID-19 Drug API Market Size by Type (2021-2026) & (US$ Million) Table 72. Europe COVID-19 Drug API Market Size by Type (2027-2032) & (US$ Million) Table 73. Europe COVID-19 Drug API Market Size by Application (2021-2026) & (US$ Million) Table 74. Europe COVID-19 Drug API Market Size by Application (2027-2032) & (US$ Million) Table 75. Europe COVID-19 Drug API Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. Europe COVID-19 Drug API Market Size by Country (2021-2026) Table 77. Europe COVID-19 Drug API Market Size by Country (2027-2032) Table 78. China COVID-19 Drug API Market Size by Type (2021-2026) & (US$ Million) Table 79. China COVID-19 Drug API Market Size by Type (2027-2032) & (US$ Million) Table 80. China COVID-19 Drug API Market Size by Application (2021-2026) & (US$ Million) Table 81. China COVID-19 Drug API Market Size by Application (2027-2032) & (US$ Million) Table 82. Asia COVID-19 Drug API Market Size by Type (2021-2026) & (US$ Million) Table 83. Asia COVID-19 Drug API Market Size by Type (2027-2032) & (US$ Million) Table 84. Asia COVID-19 Drug API Market Size by Application (2021-2026) & (US$ Million) Table 85. Asia COVID-19 Drug API Market Size by Application (2027-2032) & (US$ Million) Table 86. Asia COVID-19 Drug API Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Asia COVID-19 Drug API Market Size by Country (2021-2026) Table 88. Asia COVID-19 Drug API Market Size by Country (2027-2032) Table 89. South America, Middle East & Africa COVID-19 Drug API Market Size by Type (2021-2026) & (US$ Million) Table 90. South America, Middle East & Africa COVID-19 Drug API Market Size by Type (2027-2032) & (US$ Million) Table 91. South America, Middle East & Africa COVID-19 Drug API Market Size by Application (2021-2026) & (US$ Million) Table 92. South America, Middle East & Africa COVID-19 Drug API Market Size by Application (2027-2032) & (US$ Million) Table 93. South America, Middle East & Africa COVID-19 Drug API Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. South America, Middle East & Africa COVID-19 Drug API Market Size by Country (2021-2026) Table 95. South America, Middle East & Africa COVID-19 Drug API Market Size by Country (2027-2032) Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. COVID-19 Drug API Product Image Figure 2. Global COVID-19 Drug API Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global COVID-19 Drug API Market Share by Type: 2025 VS 2032 Figure 4. Hydroxychloroquine Image Figure 5. Chloroquine Phosphate Image Figure 6. Others Image Figure 7. Global COVID-19 Drug API Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global COVID-19 Drug API Market Share by Application: 2025 VS 2032 Figure 9. Tablet Image Figure 10. Injection Image Figure 11. Global COVID-19 Drug API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 13. Global COVID-19 Drug API Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global COVID-19 Drug API Market Share by Players in 2025 Figure 16. Global Top 5 and 10 COVID-19 Drug API Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global COVID-19 Drug API Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global COVID-19 Drug API Revenue Market Share by Type (2021-2032) Figure 20. Global COVID-19 Drug API Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global COVID-19 Drug API Revenue Market Share by Application (2021-2032) Figure 22. North America COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 23. North America COVID-19 Drug API Market Share by Type (2021-2032) Figure 24. North America COVID-19 Drug API Market Share by Application (2021-2032) Figure 25. North America COVID-19 Drug API Market Share by Country (2021-2032) Figure 26. United States COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 27. Canada COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 28. Mexico COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 29. Europe COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 30. Europe COVID-19 Drug API Market Share by Type (2021-2032) Figure 31. Europe COVID-19 Drug API Market Share by Application (2021-2032) Figure 32. Europe COVID-19 Drug API Market Share by Country (2021-2032) Figure 33. Germany COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 34. France COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 35. U.K. COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 36. Italy COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 37. Russia COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 39. China COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 40. China COVID-19 Drug API Market Share by Type (2021-2032) Figure 41. China COVID-19 Drug API Market Share by Application (2021-2032) Figure 42. Asia COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 43. Asia COVID-19 Drug API Market Share by Type (2021-2032) Figure 44. Asia COVID-19 Drug API Market Share by Application (2021-2032) Figure 45. Asia COVID-19 Drug API Market Share by Country (2021-2032) Figure 46. Japan COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 47. South Korea COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 50. India COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 51. Australia COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa COVID-19 Drug API Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa COVID-19 Drug API Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa COVID-19 Drug API Market Share by Country (2021-2032) Figure 56. Brazil COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 57. South Africa COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 59. Turkey COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 60. Argentina COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 61. UAE COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 62. Egypt COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 63. Chile COVID-19 Drug API Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Hydroxychloroquine
  • Chloroquine Phosphate
  • Others
Applications
  • Tablet
  • Injection
Companies covered
  • Chongqing Kangle Pharmaceutical Co., Ltd.
  • Fuan Pharmaceutical Group
  • Wuhan Wuyao Pharmaceutical Co., Ltd
  • Cinkate
  • Shanghai Zhongxi Sunve Pharma Co., Ltd.
  • Shenhua Pharmaceutical Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global COVID-19 Drug API Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Hydroxychloroquine
  5. 1.2.3 Chloroquine Phosphate
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global COVID-19 Drug API Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Tablet
  10. 1.3.3 Injection
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global COVID-19 Drug API Growth Trends by Region
  13. 1.5.1 Global COVID-19 Drug API Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 COVID-19 Drug API Market Size by Region (2021-2026)
  15. 1.5.3 COVID-19 Drug API Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global COVID-19 Drug API Market Dynamics
  1. 2.1 COVID-19 Drug API Industry Trends
  2. 2.2 COVID-19 Drug API Industry Drivers
  3. 2.3 COVID-19 Drug API Industry Opportunities and Challenges
  4. 2.4 COVID-19 Drug API Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global COVID-19 Drug API Revenue by Company (2021-2026)
  2. 3.2 Global COVID-19 Drug API Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global COVID-19 Drug API Key Company Head office and Area Served
  4. 3.4 Global COVID-19 Drug API Company, Product Type & Application
  5. 3.5 Global COVID-19 Drug API Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global COVID-19 Drug API Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 COVID-19 Drug API Players Market Share by Revenue in 2025
  9. 3.6.3 2025 COVID-19 Drug API Tier 1, Tier 2, and Tier 3
4 COVID-19 Drug API Market by Type
  1. 4.1 Global COVID-19 Drug API Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global COVID-19 Drug API Market Size by Type (2021-2032)
  3. 4.3 Global COVID-19 Drug API Market Size Share by Type (2021-2032)
5 COVID-19 Drug API Market by Application
  1. 5.1 Global COVID-19 Drug API Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global COVID-19 Drug API Market Size by Application (2021-2032)
  3. 5.3 Global COVID-19 Drug API Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Chongqing Kangle Pharmaceutical Co., Ltd.
  2. 6.1.1 Chongqing Kangle Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Chongqing Kangle Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Product Portfolio
  6. 6.1.5 Chongqing Kangle Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Fuan Pharmaceutical Group
  8. 6.2.1 Fuan Pharmaceutical Group Company Information
  9. 6.2.2 Fuan Pharmaceutical Group Business Overview
  10. 6.2.3 Fuan Pharmaceutical Group COVID-19 Drug API Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Fuan Pharmaceutical Group COVID-19 Drug API Product Portfolio
  12. 6.2.5 Fuan Pharmaceutical Group Recent Developments
  13. 6.3 Wuhan Wuyao Pharmaceutical Co., Ltd
  14. 6.3.1 Wuhan Wuyao Pharmaceutical Co., Ltd Company Information
  15. 6.3.2 Wuhan Wuyao Pharmaceutical Co., Ltd Business Overview
  16. 6.3.3 Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Product Portfolio
  18. 6.3.5 Wuhan Wuyao Pharmaceutical Co., Ltd Recent Developments
  19. 6.4 Cinkate
  20. 6.4.1 Cinkate Company Information
  21. 6.4.2 Cinkate Business Overview
  22. 6.4.3 Cinkate COVID-19 Drug API Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Cinkate COVID-19 Drug API Product Portfolio
  24. 6.4.5 Cinkate Recent Developments
  25. 6.5 Shanghai Zhongxi Sunve Pharma Co., Ltd.
  26. 6.5.1 Shanghai Zhongxi Sunve Pharma Co., Ltd. Company Information
  27. 6.5.2 Shanghai Zhongxi Sunve Pharma Co., Ltd. Business Overview
  28. 6.5.3 Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Product Portfolio
  30. 6.5.5 Shanghai Zhongxi Sunve Pharma Co., Ltd. Recent Developments
  31. 6.6 Shenhua Pharmaceutical Co., Ltd
  32. 6.6.1 Shenhua Pharmaceutical Co., Ltd Company Information
  33. 6.6.2 Shenhua Pharmaceutical Co., Ltd Business Overview
  34. 6.6.3 Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Product Portfolio
  36. 6.6.5 Shenhua Pharmaceutical Co., Ltd Recent Developments
7 North America
  1. 7.1 North America COVID-19 Drug API Market Size (2021-2032)
  2. 7.2 North America COVID-19 Drug API Market Size by Type
  3. 7.2.1 North America COVID-19 Drug API Market Size by Type (2021-2026)
  4. 7.2.2 North America COVID-19 Drug API Market Size by Type (2027-2032)
  5. 7.2.3 North America COVID-19 Drug API Market Share by Type (2021-2032)
  6. 7.3 North America COVID-19 Drug API Market Size by Application
  7. 7.3.1 North America COVID-19 Drug API Market Size by Application (2021-2026)
  8. 7.3.2 North America COVID-19 Drug API Market Size by Application (2027-2032)
  9. 7.3.3 North America COVID-19 Drug API Market Share by Application (2021-2032)
  10. 7.4 North America COVID-19 Drug API Market Size by Country
  11. 7.4.1 North America COVID-19 Drug API Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America COVID-19 Drug API Market Size by Country (2021-2026)
  13. 7.4.3 North America COVID-19 Drug API Market Size by Country (2027-2032)
  14. 7.4.4 North America COVID-19 Drug API Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe COVID-19 Drug API Market Size (2021-2032)
  2. 8.2 Europe COVID-19 Drug API Market Size by Type
  3. 8.2.1 Europe COVID-19 Drug API Market Size by Type (2021-2026)
  4. 8.2.2 Europe COVID-19 Drug API Market Size by Type (2027-2032)
  5. 8.2.3 Europe COVID-19 Drug API Market Share by Type (2021-2032)
  6. 8.3 Europe COVID-19 Drug API Market Size by Application
  7. 8.3.1 Europe COVID-19 Drug API Market Size by Application (2021-2026)
  8. 8.3.2 Europe COVID-19 Drug API Market Size by Application (2027-2032)
  9. 8.3.3 Europe COVID-19 Drug API Market Share by Application (2021-2032)
  10. 8.4 Europe COVID-19 Drug API Market Size by Country
  11. 8.4.1 Europe COVID-19 Drug API Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe COVID-19 Drug API Market Size by Country (2021-2026)
  13. 8.4.3 Europe COVID-19 Drug API Market Size by Country (2027-2032)
  14. 8.4.4 Europe COVID-19 Drug API Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China COVID-19 Drug API Market Size (2021-2032)
  2. 9.2 China COVID-19 Drug API Market Size by Type
  3. 9.2.1 China COVID-19 Drug API Market Size by Type (2021-2026)
  4. 9.2.2 China COVID-19 Drug API Market Size by Type (2027-2032)
  5. 9.2.3 China COVID-19 Drug API Market Share by Type (2021-2032)
  6. 9.3 China COVID-19 Drug API Market Size by Application
  7. 9.3.1 China COVID-19 Drug API Market Size by Application (2021-2026)
  8. 9.3.2 China COVID-19 Drug API Market Size by Application (2027-2032)
  9. 9.3.3 China COVID-19 Drug API Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia COVID-19 Drug API Market Size (2021-2032)
  2. 10.2 Asia COVID-19 Drug API Market Size by Type
  3. 10.2.1 Asia COVID-19 Drug API Market Size by Type (2021-2026)
  4. 10.2.2 Asia COVID-19 Drug API Market Size by Type (2027-2032)
  5. 10.2.3 Asia COVID-19 Drug API Market Share by Type (2021-2032)
  6. 10.3 Asia COVID-19 Drug API Market Size by Application
  7. 10.3.1 Asia COVID-19 Drug API Market Size by Application (2021-2026)
  8. 10.3.2 Asia COVID-19 Drug API Market Size by Application (2027-2032)
  9. 10.3.3 Asia COVID-19 Drug API Market Share by Application (2021-2032)
  10. 10.4 Asia COVID-19 Drug API Market Size by Country
  11. 10.4.1 Asia COVID-19 Drug API Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia COVID-19 Drug API Market Size by Country (2021-2026)
  13. 10.4.3 Asia COVID-19 Drug API Market Size by Country (2027-2032)
  14. 10.4.4 Asia COVID-19 Drug API Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa COVID-19 Drug API Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa COVID-19 Drug API Market Size by Type
  3. 11.2.1 South America, Middle East & Africa COVID-19 Drug API Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa COVID-19 Drug API Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa COVID-19 Drug API Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa COVID-19 Drug API Market Size by Application
  7. 11.3.1 South America, Middle East & Africa COVID-19 Drug API Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa COVID-19 Drug API Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa COVID-19 Drug API Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa COVID-19 Drug API Market Size by Country
  11. 11.4.1 South America, Middle East & Africa COVID-19 Drug API Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa COVID-19 Drug API Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa COVID-19 Drug API Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa COVID-19 Drug API Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst